Does the treatment of type 2 diabetes mellitus with the DPP-4 inhibitor vildagliptin reduce HbA1c to a greater extent in Japanese patients than in Caucasian patients? by Foley JE, Bhosekar V, Kawamori R

Get full text

A variant within the FTO confers susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes by Taira, M, Imamura, M, Takahashi, A, Kamatani, Y, Yamauchi, T, Araki, S, Tanaka, N, van Zuydam, N, Ahlqvist, E, Toyoda, M, Umezono, T, Kawai, K, Imanishi, M, Watada, H, Suzuki, D, Maegawa, H, Babazono, T, Kaku, K, Kawamori, R, Summit Consortium, Groop, L, McCarthy, M, Kadowaki, T, Maeda, S

Genetic variations in the gene encoding TFAP2B are associated with type 2 diabetes mellitus. by Maeda, S, Tsukada, S, Kanazawa, A, Sekine, A, Tsunoda, T, Koya, D, Maegawa, H, Kashiwagi, A, Babazono, T, Matsuda, M, Tanaka, Y, Fujioka, T, Hirose, H, Eguchi, T, Ohno, Y, Groves, C, Hattersley, A, Hitman, G, Walker, M, Kaku, K, Iwamoto, Y, Kawamori, R, Kikkawa, R, Kamatani, N, McCarthy, M